abnormal response/metabolism to endogenous compounds_Pld2<tm1.1Gdp>/Pld2<tm1.1Gdp>

http://metadb.riken.jp/0003638I129X1SvJC57BL6Pld2tm11GdpPld2tm11GdpPld2tm11Gdp

abnormal response/metabolism to endogenous compounds_Pld2<tm1.1Gdp>/Pld2<tm1.1Gdp>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• phospholipase D2
  http://metadb.riken.jp/db/mgi_rdf/MGI:892877

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Pld2<tm1.1Gdp>/Pld2<tm1.1Gdp>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Pld2<tm1.1Gdp>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129X1/SvJ * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal response/metabolism to endogenous compounds
  http://purl.obolibrary.org/obo/MP_0003638

文献

http://purl.org/net/cito/citesAsAuthority

• Tiago Gil. Oliveira, et.al., Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits., The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, 30
  http://rdf.ncbi.nlm.nih.gov/pubmed/21147981